Armin Spura
Chief Executive Officer bij CROWN BIOSCIENCE INTERNATIONAL
Profiel
Armin Spura is associated with Crown Bioscience, Inc. and Crown Bioscience International as their Chief Executive Officer since 2020.
Actieve functies van Armin Spura
| Bedrijven | Functie | Begin |
|---|---|---|
| CROWN BIOSCIENCE INTERNATIONAL | Chief Executive Officer | 01-04-2020 |
Crown Bioscience, Inc.
 Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Chief Executive Officer | 01-04-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Crown Bioscience, Inc.
Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Commercial Services |
Crown Bioscience International
 Crown Bioscience International BiotechnologyHealth Technology Crown Bioscience International develops drug for Oncology and Metabolic Diseases. Its products include Antibodies for in vivo & in vitro studies, Tissues for CVMD research and therapeutic R&D, Recombinant cell lines, Tumor samples for oncology research & drug development. The company founded on October 22, 2013 and is headquartered in Taipei, Taiwan. | Health Technology |
